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Background: Patients with chronic venous disease (CVD) often ask whether elective vein surgery could be delayed without
consequences. Because the natural history of CVD is not well known, this study was designed to determine its progression
in such patients.
Methods: One hundred and sixteen limbs in 90 patients who had at least 2 exams with duplex ultrasound (DU) scanning
prior to vein surgery at a university medical center were studied. These were patients who were offered an operation but
for various reasons were treated at a later stage. Patients were classified by the CEAP system.
Results: The mean age of the patients was 49 years (range, 23 to 81 years). A second DU scan was performed 1 to 43
months after the initial exam (median, 19 months). Eighty-five limbs (73.3%) were unchanged. Thirteen limbs (11.2%)
had progression of clinical stage, and seven had progression on DU scanning as well. Seven limbs progressed from C2 to
C3, four limbs from C3 to C4, and two limbs from C4 to C6. Thirty-four limbs had a documented change on repeat DU
scanning. In 3 of these limbs, reflux was missed on the initial exam; therefore, 31 limbs had progression of disease. The
great saphenous vein and tributaries were the most often anatomic sites affected by a change, followed by perforators.
Seventeen limbs (14.7%) had extension of pre-existing reflux, and 14 (12.1%) had reflux in a new segment. In 11 of these
limbs, a change in the initial plan for treatment was required. Symptomatic or DU changes were noted 6 months or later
in 95% of limbs and 74.2% of limbs with disease progression were diagnosed at 12 months or later. All but one of the 13
symptomatic limbs developed symptoms at least a year later.
Conclusion: Nearly one third of patients with venous reflux had progression. Anatomic extension is frequent with disease
progression but not a pre-requisite. Progression was found in most limbs 6 months after the initial study. Patients
undergoing treatment for their veins may need another DU exam if this time interval is exceeded. (J Vasc Surg 2005;41:
291-5.)Chronic venous disease (CVD) is the most common
vascular disorder.1 It is caused by venous hypertension due
to either reflux, outflow obstruction, or both,2 and its
clinical presentation varies from a small cosmetic imperfec-
tion to chronic ulceration. The quality of life of patients
with CVD may be impaired because of pain, physical limi-
tation, immobility, and social seclusion.3
The management of CVD has been mainly empirical
throughout the years, given that its pathophysiology, dis-
tribution, and natural history are not fully known. The
advent of duplex ultrasound (DU) technology and recent
improvements in the classification of CVD4 have signifi-
cantly enhanced our understanding. Studies on its natural
history and progression are scarce; therefore, no available
information accurately describes the evolution of CVD.
This study was conducted to determine the progression
of CVD and, more specifically, to identify changes in the
distribution and extent of reflux in patients with CVD who
are waiting for treatment.
METHODS
Data on patients with evidence of CVD were prospec-
tively entered in a customized database. These patients
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doi:10.1016/j.jvs.2004.11.014were offered treatment for varicose veins, but for several
reasons, they did not undergo a timely intervention.
Rather, treatment was given at a later stage. They had to
have at least two DU examinations prior to intervention to
be included. A history and physical examination were per-
formed in all patients in the original as well as in subsequent
visits. The CEAP classification was used to grade the sever-
ity of CVD.4
Color-flow DU scanning was used for reflux determi-
nation. Multifrequency 4-7–MHz linear array transducers
weremost commonly used. For veins located 1 cm from the
skin within the subcutaneous tissues, 10-MHz transducers
were used instead. For veins located more than 6 cm from
the skin, 3-MHz transducers were preferred. The veins
were evaluated in the standing position. The examination,
which included the femoropopliteal, deep calf veins, great
(GSV) and small (SSV) saphenous veins and their tributar-
ies, and nonsaphenous veins (when present), followed tech-
niques that have been described elsewhere.5
The distribution and patterns of reflux were registered.
Reflux was induced by distal limb compression followed by
sudden release using rapid-inflation pneumatic cuffs (Air-
cast, Summit, NJ) with a maximum pressure of 80 mmHg.
It was considered to be present when retrograde flow lasted
more than 0.5 seconds for the superficial or the deep calf
veins, more than 350 milliseconds for the perforator veins,
and more than 1 second for the femoropopliteal veins.6
New reflux sites or anatomic extension of reflux at a previ-
ously documented site were sought. A detailed map of the
normal and the incompetent sites was drawn on a specially
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cular, and bony landmarks. This allowed for a precise
documentation of the distribution and extent of reflux and
accurate comparisons to be made with subsequent exams.
Statistics. Descriptive statistics were used for the anal-
ysis of the patients’ characteristics and outcome. Prevalence
of CVD classes and other features in the CEAP classifica-
tion were compared with a 2 test. The prevalence of
changes in reflux patterns in the second DU scan was
compared with the Fisher exact test.
RESULTS
The study included 116 limbs in 90 patients (64 uni-
lateral limbs, 26 bilateral). There were 31 men and 59
women, and their mean SD age was 49 8 years (range,
23 to 81). Seventy-three patients had a known family
history of CVD. Ninety-eight limbs (84.5%) were symp-
tomatic, and in the rest, treatment was requested for cos-
metic reasons. The clinical classification of the limbs ac-
cording to CEAP is shown in Table I. CVD class 2, primary
Table III. Anatomic distribution of changed duplex
ultrasound examinations
SFJ GSV SSV TRB NSV Prf Deep Total
New site 0 2 1 4 1 4 2 14
Extension 1 5 3 3 2 2 1 17
Total 1 7 4 7 3 6 3 31
SFJ, Saphenofemoral junction;GSV, great saphenous vein; SSV, small saphe-
nous vein; TRB, tributaries;NSV, nonsaphenous veins; Prf, perforator veins.
Extension vs new sites (P  .46).
Saphenous system vs any other veins separately (P  .001).
Saphenous system vs all others (P  .13).
Table I. Classification of limbs according to CEAP
C n (%) E n (%)
0 0 (0) EC 0 (0)
1 4 (3.4) EP 108 (93.1)
2 56 (48.3) ES 1 (0.9)
3 27 (23.3) EP  S 7 (6)
4 16 (13.8)
5 8 (6.9)
6 5 (4.3)
Total
C, Clinical classification; E, etiologic classification (ES, congenital; EP, pri
AD, deep); P, pathophysiologic classification (R, reflux; O, obstruction).
Table II. Timing of repeated duplex ultrasound testing
Time(months) 1-3 4-6 7-9 10-12
n 15 28 18 15
n with change 1 5* 6 3
symptoms 1 1
n, Number of duplex ultrasound exams within the noted time interval.
*4 limbs had a change at 6 months.disease, and reflux were the most prevalent features (P .0001 for all comparisons). Most limbs had superficial vein
reflux, but the perforator veins were incompetent in 31% of
limbs and the deep, in 20% of limbs.
Reasons to undergo a repeated DU exam included
preoperative venous mapping in 74 patients and develop-
ment of new symptomatology in 13. Twenty-nine patients
sought treatment at least a year after the initial assessment,
and the treating physician requested a new exam. The
second DU scan was performed between 1 and 43 months
after the initial test (median, 19 months).
The repeated examination revealed no change in 85
limbs (73.3%) and changes in 31. Three of the 85 un-
changed cases were initially thought to have new findings.
After reanalysis of the original exam, it was concluded that
these were missed in the first test. The anatomic location of
the missed findings included a case of duplicated popliteal
vein, a vulvar vein, and a posteromedial perforator at the
mid calf. The changes occurred in 29 (29.6%) symptomatic
limbs and only in 2 (11.1%) asymptomatic limbs (P .18).
The time at which the repeated exam occurred is dis-
played in Table II. A change either in the symptoms or in
DU findings occurred at 6 months or later in 38 (95%) of
40 limbs. Of the 13 symptomatic limbs, symptoms devel-
oped in 12 at 12 months or later.
The anatomic distribution of the changed cases is
shown in Table III. The venous segments that were more
commonly affected by new findings were the saphenous
veins and their tributaries (P  .001). The latter were
tributaries to the GSV in five patients and to the SSV in two.
In 14 limbs, new sites of reflux were found that were not in
continuity with the existing incompetent sites. In 17 limbs,
reflux extended from pre-existing incompetent veins. The
extension occurred in antegrade fashion in seven, retro-
A n (%) P n (%)
S 64 (55.2) R 113 (97.4)
S  P 29 (25) O 0 (0)
P 0 (0) R  O 3 (2.6)
S  D 16 (13.8)
D 0 (0)
S  P  D 7 (6)
otal 116 (100)
116
ES, secondary); A, anatomic classification (AS, superficial; AP, perforator;
19-24 25-30 31-36 37-43 Total
10 8 7 3 116
3 2 3 1 27
3 2 2 1 13A
A
A
A
A
A
T13-18
12
3
3grade in seven, and in both directions in three. The 14
umbe
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a change of the initial treatment for CVD. In four of those,
the change was in tributaries. One of them was an obese
patient in whom the clinical exam would have been unable
to determine the new site of reflux. Therefore, 11 limbs
with new reflux sites would require additional treatment.
Patients who developed new signs or symptoms re-
ported swelling in seven cases, skin changes in four, and
ulceration in two. All patients who reported swelling pro-
gressed from CEAP clinical class 2 to 3; all those who
reported skin changes went from class 3 to 4, and all those
who reported ulcers went from class 4 to 6. Among patients
with new signs or symptoms, new DU findings were en-
countered in 7 (53.8%) of 13, which was significantly
higher than the 24 (23.3%) of 103 patients without new
symptoms (P  .04). The anatomic location of the new
findings and the time when those were found are depicted
in Table IV.
DISCUSSION
Only a few longitudinal studies have been reported on
the natural history of primary CVD. Most of the available
information arises from cross-sectional studies, and there-
fore, the characteristics of CVD progression remain poorly
understood.7 Sarin et al8 evaluated 36 patients admitted for
varicose vein surgery who underwent repeated DU scans
and photoplethysmography prior to intervention. The me-
dian time between the first and second examwas 20months
(range, 15 to 27). Clinical development of varicose veins
was noted in 5 of 16 previously normal limbs. The number
of patients with varicosities initially located in the GSV
distribution increased by 3 and in the SSV by 11. Among
limbs with normal initial DU scans, four (25%) developed
new reflux. The number of limbs affected by SFJ reflux
increased by five, SPJ reflux by nine, and no new cases of
deep reflux were noted. Among those with evidence of
clinical disease, 10 (18%) developed further sources of
insufficiency and needed extension of the planned interven-
tion. Lastly, no differences in photoplethysmographic re-
sults were seen. Their conclusions cannot be fully validated,
given the small number of limbs involved. The large occur-
rence of newly developed SFJ and SPJ insufficiency may be
partly due to reflux that was missed in the original exami-
nation, like the three misdiagnosed cases in the current
study.
The current study included patients that did not un-
dergo intervention at the time it was originally intended.
Table IV. Anatomy of new findings and timing among pa
Symptoms Swelling (4/7)*
Timing (months) 8 14 2
Anatomic distribution† 1 GSV AK 1 PV  1 TRB 1
PV, perforator vein; TRB, tributary vein; GSV AK, above-the-knee great sa
*In parenthesis are number of cases with duplex ultrasound changes over n
†In the anatomic distribution, every column represents changes in a singleThe reasons for this were several and included insurancematters, patients’ change of opinion about an intervention,
or unavailability of treating physician or patients at the
scheduled time of intervention. One quarter of the studied
limbs belonged to CEAP classes 4 to 6, a reflection of the
unselected nature and the severity of CVD in this popula-
tion.
Sarin et al8 recommended a full limb reassessment prior
to surgery in patients waiting at any length of time. But
their data did not include the timing of diagnosis of clinical
change or DU change (or both) in the pattern of insuffi-
ciency. The present study demonstrated that 73% of limbs
did not develop any change. In almost all limbs that were
noted to have CVD progression, it had developed 6
months after the original test. Furthermore, this occurred
at least a year later in 12 of the 13 limbs that developed new
signs or symptoms. This allows us to suggest that another
DU scan should be performed when 6 months or more
have elapsed since the initial test, as the disease progression
cannot be identified in all cases by the physical examination.
The development of new symptoms in this subset of
patients was accompanied by a parallel change in DU
findings in about half of the limbs. This carries important
implications. History and physical examination cannot re-
liably identify those patients in whom venous reflux
changes develop over time. It has been shown that large
intraobserver and interobserver variability exists in the clin-
ical assessment of patients with CVD.9 Likewise, a number
of patients did not have any changes on their DU scan and
yet were noted to have progression of disease. This finding
should deter the practitioner from being reassured by a
patient who denies new symptomatology in the time inter-
val between testing. It also indicates the inability of ultra-
sound scanning to evaluate refilling times and the efficiency
of calf muscle pump. Physiologic testing would give this
information, and in cases like that, a combination of ana-
tomic and physiologic tests would be preferable.
In three patients, missing findings were noted after a
comparison and reanalysis of all DU examinations. If the
second DU scan had not been performed, they might have
undergone an insufficient intervention for their condition
and potentially needed further treatment. Careful assess-
ment of all venous segments as previously described and
awareness of the different venous anatomic variants should
lead to fewer false-negative results and to a more efficient
management of patients with CVD.
Another longitudinal study10 attempted to investigate
the preclinical and early stages of the development of
s with new symptoms
Skin changes (2/4) Ulceration (1/2)
34 16 23 34
1 GSV  1 PV 1 GSV AK 2 PV 1 PV  1 POPV
us vein; SSV, small saphenous vein; POPV, popliteal vein.
r of cases that developed new symptoms.
t (n  7).tient
6
SSV
phenovaricosities. A large cohort of children from 10 to 12 years
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later with history, physical examination, continuous-wave
Doppler scanning and photoplethysmography. DU scan-
ning was used in addition only in the last follow-up. The
presence of telangiectasias and reticular veins were noted
early on, independently of the presence of reflux. Large
varicosities appeared in older subjects, and they were often
preceded by reflux in the saphenous veins. However, this
would be difficult to prove, as DU scanning was not used in
the first two time points. Although the focus of this work is
very different than the current, it adds valuable information
with regard to the pathophysiology of varicose veins. These
landmark manuscripts represent the initial effort to investi-
gate the natural history and evolution of CVD.
Two other papers were presented by the same
group11,12 on patients with both superficial and deep ve-
nous reflux. A deterioration in the clinical class was shown
in most of the limbs at the observation period. Limbs that
underwent a superficial or deep venous procedure remained
stable or improved over time. Limbs that underwent elastic
compression alone had worsening hemodynamic and clin-
ical status.
Anatomic distribution of DU changes
The most frequent anatomic locations affected by a
change in the current study were the saphenous veins and
their tributaries, followed by perforators. The affected trib-
utaries depended on the GSV in five patients and on the
SSV in two. This disagrees with the work of Sarin et al,8
who reported DU changes mostly affecting the SPJ and the
SFJ. However, our results are supported by a previous
cross-sectional study that analyzed individuals with CVD
classes 0 to 2. It was shown that the main trunk of GSV and
its tributaries were the most prevalent sites for reflux,
regardless of their clinical stage.13
Reflux extension in antegrade and retrograde fashion
was detected in continuity with pre-existing incompetent
sites and reflux in new locations independent of the pre-
existing disease. This contradicts the traditional assumption
that primary reflux develops starting at the SFJ level and
proceeds in a retrograde manner. It has been previously
shown that reflux can take place without junctional involve-
ment, often affecting different veins that may not commu-
nicate with each other.13 The current data support these
findings and indicate that reflux may develop at one or
different locations and can progress in a retrograde or
antegrade manner, and in both directions.
Surgical treatment
Patients that develop a change in DU testing may
require a modification of the previously planned interven-
tion. These modifications depend on the anatomic region,
the surgeon’s preference, and the nature of the change. In
our study, 11 limbs potentially would have had a change in
their treatment that would not be apparent by the clinical
exam (Table III). As these were new sites of reflux and not
just an extension of a pre-existing segment, they could have
been easily overlooked.Saphenofemoral junction. Only one patient had re-
flux extension into the SFJ. Flush SFJ ligation, stripping of
the above knee segment of GSV, and phlebectomies in the
affected tributaries were performed. If endovenous ablation
had been performed, the SFJ would have been left intact as
during the procedure the SFJ is spared.
Saphenous veins. Three developed reflux in previ-
ously normal saphenous veins, while eight developed an
extension at a pre-existing site. These cases are particularly
difficult to address clinically because of their anatomic
location in the saphenous compartment, and treatment
may be altered depending on the anatomic position and the
severity of reflux.
Nonsaphenous veins. One case of a nonsaphenous
vein (vein of the sciatic nerve) with newly diagnosed reflux
required an extension of the planned therapy. This was
addressed by subfascial ligation and local avulsions.
Tributaries. Four limbs had new reflux diagnosed in a
tributary vein, and three limbs had extension of disease and
were addressed only by additional phlebectomies.
Perforators. Four cases of new reflux involving perfo-
rating veins were treated with phlebectomies of the sur-
rounding tributaries and ligation of two large perforators.
The management of perforator reflux is a matter of debate,
but in patients with competent deep veins, perforator reflux
is often abolished after eradication of saphenous vein
reflux.14
Deep veins. Two limbs developed new reflux and
compression stockings were prescribed. In patients with
combined deep and superficial vein reflux, elimination of
the latter results in resolution of the former in about one
third to one half of patients.15, 16
CONCLUSION
Approximately one third of patients with CVD develop
progression, which in 95% starts at 6 months or later after
the initial study. Progression includes anatomic extension
in most cases, development of reflux in new venous seg-
ments or a combination of both, and clinical deterioration.
The appearance or absence of new symptoms during the
interval period cannot consistently identify patients who
will develop reflux changes over time. The findings of the
current study allow us to suggest that patients undergoing
interventions for varicose veins may require another DU
scan if more than 6 months have passed since the original
exam. This is not a population-based study, and these
findings cannot be applied to all patients with CVD. To
assess the natural history of venous disease, DU scanning
and hemodynamic testing should be used at set time inter-
vals in prospective long-term studies with a large sample
size.
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